Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking ...

AliveDx has obtained European In Vitro Diagnostic Device Regulation (IVDR) CE mark certification for its MosaiQ AiPlex CD ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

The certification will allow Ventripoint to engage in the next steps of country-specific entrance of VMS+4.0 in the European Union (EU) and other geographies that recognize CE marking. VMS+4.0 ...

In addition to receiving CE marking, HFX iQ received U.S. Food and Drug Administration (FDA) approval in 2022. Nevro will offer the HFX iQ system in select European countries starting in the first ...

Detailed price information for Ventripoint Diagnostics Ltd (VPTDF) from The Globe and Mail including charting and trades.

Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, ...

Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced ...